This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We'd like to congratulate FundersClub portfolio companies on their ongoing progress, as well as to welcome aboard their new VC investor partners. Selected recent FundersClub portfolio company follow-on rounds: UpKeep announced its $36M Series B led by Insight Partners for its mobile-first CMMS software that makes technicians more agile and maintenance teams more productive.
“David Talby, CTO of John Snow Labs, echoed the sentiment. ‘Healthcare data scientists & analysts need the right data and context to succeed, and we’re committed to clearing the way to get them there. The combination of our medical domain expertise, three levels of quality reviews, and always-current data with data.world’s discovery, community, and enrichment capabilities are a natural match to help accelerate the healthcare research community.'” Read more here.
On today, Memorial Day, we remember our fallen soldiers. I spent some time today going back over old blog posts I’ve written on this topic and landed on a post I wrote almost ten years ago , when I visited the Normandy beaches with my wife and son. It was a very powerful and moving experience for us. I am glad we take a day every year to remember the men and women who lost their lives in service of our country.
Despite Israel’s unprecedented unemployment situation, high-tech companies are still recruiting. As Israel carefully re-opens for business, startups have a huge role to play in getting our nation back to work. OurTalent, OurCrowd’s jobs portal, currently lists hundreds of vacant positions from within its portfolio companies, with fresh opportunities added each week.
Speaker: Lee Andrews, Founder at LJA New Media & Tony Karrer, Founder and CTO at Aggregage
This session will walk you through how one CEO used generative AI, workflow automation, and sales personalization to transform an entire security company—then built the Zero to Strategy framework that other mid-market leaders are now using to unlock 3.5x ROI. As a business executive, you’ll learn how to assess AI opportunities in your business, drive adoption across teams, and overcome internal resource constraints—without hiring a single data scientist.
However, vaccine development, like drug development, is a long and complicated process. And it doesn’t always succeed, explains industry expert Ron Ellis, editor in chief of Human Vaccines & Immunotherapeutics and a consultant for Israeli vaccine development company MigVax. Read more here. The post [MigVax in Israel21C] In the race for a coronavirus vaccine, first doesn’t mean best appeared first on OurCrowd.
VANCOUVER, May 25, 2020 /CNW/ – SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced it enrolled its first participant on May 12, 2020 in a multi-centre Phase II trial of its Nitric Oxide Releasing Solution (NORSTM) for the prevention and early treatment of COVID-19. The Company is continuing enrolment in British Columbia and will initiate enrolment in Quebec on June 1.
VANCOUVER, May 25, 2020 /CNW/ – SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced it enrolled its first participant on May 12, 2020 in a multi-centre Phase II trial of its Nitric Oxide Releasing Solution (NORSTM) for the prevention and early treatment of COVID-19. The Company is continuing enrolment in British Columbia and will initiate enrolment in Quebec on June 1.
Stellar Cyber is the key definitive cyber security guide to help deal with the never-ending, always-looming cyber threats in the digitized world. Read more here. The post [Stellar Cyber in The CXO Fortune] 10 Most Influential Companies of the Year 2020 appeared first on OurCrowd.
With the COVID-19 pandemic and associated social distancing efforts having prompted a huge uptick in the mainstream use of digital services, banks are now seeing more online activity than every before. This, in turn, is making online fraud detection more important than ever, and BioCatch has some advice about how financial services organizations can meet this need while offering a positive customer experience.
The new startup MigVax was spun out of Migal Galilee Research Institute in Kiryat Shemona, the largest regional R&D center of the Israeli Science and Technology Ministry. Read more here. The post [MigVax in Israel21C] 6 coronavirus vaccine developments from Israel to watch appeared first on OurCrowd.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content